EGF Theramed Health Corp.

Recent News

  • EGF Theramed Secures $10 Million Term Sheet Agreement

    Vancouver, British Columbia--(Newsfile Corp. - September 14, 2022) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUHP) (the "Company" of "EGF") has secured a term sheet agreement with Reef Capital, pursuant to which the lender will loan up to $10-million to EGF Theramed in ten tranches of $500,000.00 each. The Company may use any and all proceeds raised pursuant to the issuance of the Notes for acquisitions, working capital, and general corporate purposes, as determined by the...

    2022-09-14 4:02 PM EDT
  • EGF Theramed Announces New CEO and Business Expansion Plan

    Vancouver, British Columbia--(Newsfile Corp. - August 18, 2022) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUHP) (the "Company" of "EGF") is pleased to announce Connor Yuen as its new Chief Executive Officer. Mr. Connor Yuen is the founder and Chief Investment Officer of Conquest Capital, a Vancouver based private equity fund. He has successfully managed this fund in both public and private markets. Mr Yuen has excelled in his previous experience as a CEO and sits...

    2022-08-18 4:05 PM EDT
  • EGF Theramed Joint Venture Partner Pharmadelic Labs Announces Lab Services Agreement With Numinus Wellness

    Vancouver, British Columbia--(Newsfile Corp. - June 25, 2021) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) ("Theramed", the "Company") is pleased to announce that its subsidiary joint venture Pharmadelic Labs Inc. ("Pharmadelic") has signed a laboratory services agreement with Numinus Wellness Inc. (TSXV: NUMI) ("Numinus"). Pharmadelic is a biotech company focused on developing, improving and patenting engineering processes for the biosynthesis of compounds, primarily psilocybin. Through the Health Canada-licensed Numinus Bioscience lab in British Columbia, Canada, Numinus will...

    2021-06-25 4:05 PM EDT
  • EGF Theramed Health Corp. Announces $1.7m Non-brokered Private Placement and Early Stage Due Diligence on Psilocybin Assets

    Vancouver, British Columbia--(Newsfile Corp. - April 13, 2020) -  EGF Theramed Health Corp. (CSE: TMED) (OTCQB: EVAHF) (the "Company") is pleased to announce a non-brokered private placement (the "Offering") financing of up to 3,400,000 million units (the "Units") of the Company at a price of $0.50 per Unit for gross proceeds of $1,700,000. Each Unit consists of one common share and one common share purchase warrant, with each warrant entitling the holder to acquire an additional common share of the...

    2020-04-13 6:12 PM EDT
  • EGF Theramed Announces Resignation of Director and President

    Vancouver, British Columbia--(Newsfile Corp. - April 3, 2020) - EGF Theramed Health Corp. (CSE: TMED) announces that Mr. Sydney Au has resigned as a director of EGF Theramed Health Corp. and that Mr. Chris Brown has resigned as President of the company and of its subsidiary Western Agri Supply Solutions Corp. Following the resignations, the Company will be doing a full audit of company financials.The company wishes to thank Mr. Au as a founding director and his many years...

    2020-04-03 8:02 PM EDT
  • EGF Theramed Announces Change of Directors and New CEO

    Vancouver, British Columbia--(Newsfile Corp. - January 30, 2020) - EGF Theramed Health Corp. (CSE: TMED) has appointed David Bentil and Jatinder Dhaliwal to the board of EGF Theramed Health Corp. Mr. Bentil will assume the role of CEO and Mr. Dhaliwal will assume the role of director. Mr. Bentil is an Economist by trade. In 2002, he decided to follow his passion by pursuing a career in the car business which has done for over 17 years. In the same...

    2020-01-30 4:19 PM EST